BOUCHERVILLE, QC, Aug. 16, 2013 /CNW Telbec/ - Noveko International Inc.
(the "Corporation") wishes to remind its shareholders of the decision
made by the Toronto Stock Exchange to delist our Class A Shares at the
close of market on August 19, 2013 for failure by the Corporation to
meet its continued listing requirements. As mentioned in our July 18,
2013 news release, it was obvious for us that the closing of our
anticipated $10 million financing was a necessary condition to maintain
our listing on the TSX. We continue to be confident that such financing
will soon be completed.
In the meantime, we have begun the process to have our Class A Shares
listed with another Canadian Exchange. We will be able to file our
formal application only when we will be able to confirm the final
conditions and closing date for our anticipated $10 million financing.
No guarantee can however be provided that the Corporation's listing
application will be approved by this Canadian Exchange. Investors will
continue to be able to purchase or sell our Class A Shares through
their broker on the over-the-counter market but, without an organized
market, shares usually are much less liquid. We are sorry for any
inconvenience this might cause to our shareholders and hope that this
situation will soon be remedied.
Profile of the Corporation
The Corporation specializes in the air filtration segment by providing
its clientele with innovative and eco-energetic filtration solutions.
As such, through its subsidiaries, the Corporation designs, develops,
manufactures and markets air filters incorporating its patented air
filtration technologies, which filters are cleanable and recyclable,
and have a much longer life span than conventional air filters. These
filters are used in farm buildings, in institutional, commercial,
industrial and residential buildings, and in the ground and aeronautics
Through distributors, the Corporation furthermore continues to
commercialize antimicrobial masks and respirators, hands sanitizers and
ultrasound scanners for use in human and veterinary medicine.
SOURCE: NOVEKO INTERNATIONAL INC.
Gary Mc Cone
Senior Vice-President and Chief Financial Officer
Tel: (514) 875-0606
Copyright CNW Group 2013